nodes	percent_of_prediction	percent_of_DWPC	metapath
Miglustat—Cerebellar syndrome—Fludarabine—lymphatic system cancer	0.0737	0.0737	CcSEcCtD
Miglustat—Numbness—Fludarabine—lymphatic system cancer	0.0178	0.0178	CcSEcCtD
Miglustat—Sensory loss—Fludarabine—lymphatic system cancer	0.0171	0.0171	CcSEcCtD
Miglustat—Cognitive impairment—Methotrexate—lymphatic system cancer	0.0168	0.0168	CcSEcCtD
Miglustat—Neuropathy—Teniposide—lymphatic system cancer	0.0158	0.0158	CcSEcCtD
Miglustat—Menstrual disorder—Mitoxantrone—lymphatic system cancer	0.0129	0.0129	CcSEcCtD
Miglustat—Depression—Mechlorethamine—lymphatic system cancer	0.0127	0.0127	CcSEcCtD
Miglustat—Neuritis—Vincristine—lymphatic system cancer	0.0121	0.0121	CcSEcCtD
Miglustat—Haemoglobin—Mechlorethamine—lymphatic system cancer	0.0115	0.0115	CcSEcCtD
Miglustat—Haemorrhage—Mechlorethamine—lymphatic system cancer	0.0115	0.0115	CcSEcCtD
Miglustat—Visual disturbance—Fludarabine—lymphatic system cancer	0.0113	0.0113	CcSEcCtD
Miglustat—Numbness—Vincristine—lymphatic system cancer	0.0109	0.0109	CcSEcCtD
Miglustat—Sensory loss—Vincristine—lymphatic system cancer	0.0104	0.0104	CcSEcCtD
Miglustat—Cognitive disorder—Methotrexate—lymphatic system cancer	0.0101	0.0101	CcSEcCtD
Miglustat—Gait disturbance—Carmustine—lymphatic system cancer	0.0097	0.0097	CcSEcCtD
Miglustat—Gait disturbance—Vincristine—lymphatic system cancer	0.00926	0.00926	CcSEcCtD
Miglustat—Neuropathy peripheral—Teniposide—lymphatic system cancer	0.00923	0.00923	CcSEcCtD
Miglustat—Vertigo—Mechlorethamine—lymphatic system cancer	0.00897	0.00897	CcSEcCtD
Miglustat—Neuropathy—Carmustine—lymphatic system cancer	0.00889	0.00889	CcSEcCtD
Miglustat—Appetite absent—Methotrexate—lymphatic system cancer	0.00881	0.00881	CcSEcCtD
Miglustat—Haemoglobin—Teniposide—lymphatic system cancer	0.00849	0.00849	CcSEcCtD
Miglustat—Neuropathy—Vincristine—lymphatic system cancer	0.00848	0.00848	CcSEcCtD
Miglustat—Haemorrhage—Teniposide—lymphatic system cancer	0.00845	0.00845	CcSEcCtD
Miglustat—Neuropathy peripheral—Fludarabine—lymphatic system cancer	0.00811	0.00811	CcSEcCtD
Miglustat—Thrombocytopenia—Mechlorethamine—lymphatic system cancer	0.00797	0.00797	CcSEcCtD
Miglustat—Anorexia—Mechlorethamine—lymphatic system cancer	0.00776	0.00776	CcSEcCtD
Miglustat—Chills—Teniposide—lymphatic system cancer	0.00758	0.00758	CcSEcCtD
Miglustat—Haemoglobin—Fludarabine—lymphatic system cancer	0.00747	0.00747	CcSEcCtD
Miglustat—Haemorrhage—Fludarabine—lymphatic system cancer	0.00743	0.00743	CcSEcCtD
Miglustat—Hypoaesthesia—Fludarabine—lymphatic system cancer	0.00739	0.00739	CcSEcCtD
Miglustat—Amnesia—Carmustine—lymphatic system cancer	0.00731	0.00731	CcSEcCtD
Miglustat—Visual impairment—Fludarabine—lymphatic system cancer	0.00716	0.00716	CcSEcCtD
Miglustat—Decreased appetite—Mechlorethamine—lymphatic system cancer	0.00708	0.00708	CcSEcCtD
Miglustat—Chills—Fludarabine—lymphatic system cancer	0.00667	0.00667	CcSEcCtD
Miglustat—Pain in extremity—Vincristine—lymphatic system cancer	0.00656	0.00656	CcSEcCtD
Miglustat—Malnutrition—Fludarabine—lymphatic system cancer	0.00647	0.00647	CcSEcCtD
Miglustat—Ataxia—Carmustine—lymphatic system cancer	0.00646	0.00646	CcSEcCtD
Miglustat—Ataxia—Vincristine—lymphatic system cancer	0.00617	0.00617	CcSEcCtD
Miglustat—Weight decreased—Bleomycin—lymphatic system cancer	0.00616	0.00616	CcSEcCtD
Miglustat—Muscular weakness—Carmustine—lymphatic system cancer	0.00606	0.00606	CcSEcCtD
Miglustat—Ill-defined disorder—Fludarabine—lymphatic system cancer	0.006	0.006	CcSEcCtD
Miglustat—Thrombocytopenia—Teniposide—lymphatic system cancer	0.00588	0.00588	CcSEcCtD
Miglustat—Abdominal pain upper—Mitoxantrone—lymphatic system cancer	0.00583	0.00583	CcSEcCtD
Miglustat—Malaise—Fludarabine—lymphatic system cancer	0.00583	0.00583	CcSEcCtD
Miglustat—Muscular weakness—Vincristine—lymphatic system cancer	0.00579	0.00579	CcSEcCtD
Miglustat—Anorexia—Teniposide—lymphatic system cancer	0.00572	0.00572	CcSEcCtD
Miglustat—Convulsion—Fludarabine—lymphatic system cancer	0.0056	0.0056	CcSEcCtD
Miglustat—Diarrhoea—Mechlorethamine—lymphatic system cancer	0.00557	0.00557	CcSEcCtD
Miglustat—Haemoglobin—Bleomycin—lymphatic system cancer	0.00547	0.00547	CcSEcCtD
Miglustat—Haemorrhage—Bleomycin—lymphatic system cancer	0.00545	0.00545	CcSEcCtD
Miglustat—Discomfort—Fludarabine—lymphatic system cancer	0.00544	0.00544	CcSEcCtD
Miglustat—Hypoaesthesia—Bleomycin—lymphatic system cancer	0.00542	0.00542	CcSEcCtD
Miglustat—Depression—Carmustine—lymphatic system cancer	0.00528	0.00528	CcSEcCtD
Miglustat—Decreased appetite—Teniposide—lymphatic system cancer	0.00522	0.00522	CcSEcCtD
Miglustat—Neuropathy peripheral—Carmustine—lymphatic system cancer	0.00519	0.00519	CcSEcCtD
Miglustat—Vomiting—Mechlorethamine—lymphatic system cancer	0.00518	0.00518	CcSEcCtD
Miglustat—Nervous system disorder—Fludarabine—lymphatic system cancer	0.00518	0.00518	CcSEcCtD
Miglustat—Thrombocytopenia—Fludarabine—lymphatic system cancer	0.00517	0.00517	CcSEcCtD
Miglustat—Weight decreased—Vincristine—lymphatic system cancer	0.00513	0.00513	CcSEcCtD
Miglustat—Depression—Vincristine—lymphatic system cancer	0.00504	0.00504	CcSEcCtD
Miglustat—Anorexia—Fludarabine—lymphatic system cancer	0.00503	0.00503	CcSEcCtD
Miglustat—Weight decreased—Mitoxantrone—lymphatic system cancer	0.005	0.005	CcSEcCtD
Miglustat—Neuropathy peripheral—Vincristine—lymphatic system cancer	0.00496	0.00496	CcSEcCtD
Miglustat—Feeling abnormal—Teniposide—lymphatic system cancer	0.00495	0.00495	CcSEcCtD
Miglustat—Gastrointestinal pain—Teniposide—lymphatic system cancer	0.00491	0.00491	CcSEcCtD
Miglustat—Chills—Bleomycin—lymphatic system cancer	0.00489	0.00489	CcSEcCtD
Miglustat—Nausea—Mechlorethamine—lymphatic system cancer	0.00484	0.00484	CcSEcCtD
Miglustat—Haemoglobin—Carmustine—lymphatic system cancer	0.00478	0.00478	CcSEcCtD
Miglustat—Haemorrhage—Carmustine—lymphatic system cancer	0.00475	0.00475	CcSEcCtD
Miglustat—Abdominal pain—Teniposide—lymphatic system cancer	0.00475	0.00475	CcSEcCtD
Miglustat—Paraesthesia—Fludarabine—lymphatic system cancer	0.00474	0.00474	CcSEcCtD
Miglustat—Hypoaesthesia—Carmustine—lymphatic system cancer	0.00473	0.00473	CcSEcCtD
Miglustat—Connective tissue disorder—Carmustine—lymphatic system cancer	0.00467	0.00467	CcSEcCtD
Miglustat—Dyspepsia—Fludarabine—lymphatic system cancer	0.00465	0.00465	CcSEcCtD
Miglustat—Decreased appetite—Fludarabine—lymphatic system cancer	0.00459	0.00459	CcSEcCtD
Miglustat—Visual impairment—Carmustine—lymphatic system cancer	0.00458	0.00458	CcSEcCtD
Miglustat—Gastrointestinal disorder—Fludarabine—lymphatic system cancer	0.00456	0.00456	CcSEcCtD
Miglustat—Fatigue—Fludarabine—lymphatic system cancer	0.00455	0.00455	CcSEcCtD
Miglustat—Hypoaesthesia—Vincristine—lymphatic system cancer	0.00452	0.00452	CcSEcCtD
Miglustat—Constipation—Fludarabine—lymphatic system cancer	0.00451	0.00451	CcSEcCtD
Miglustat—Pain—Fludarabine—lymphatic system cancer	0.00451	0.00451	CcSEcCtD
Miglustat—Connective tissue disorder—Vincristine—lymphatic system cancer	0.00446	0.00446	CcSEcCtD
Miglustat—Eye disorder—Carmustine—lymphatic system cancer	0.00444	0.00444	CcSEcCtD
Miglustat—Haemoglobin—Mitoxantrone—lymphatic system cancer	0.00444	0.00444	CcSEcCtD
Miglustat—Haemorrhage—Mitoxantrone—lymphatic system cancer	0.00442	0.00442	CcSEcCtD
Miglustat—Ill-defined disorder—Bleomycin—lymphatic system cancer	0.0044	0.0044	CcSEcCtD
Miglustat—Feeling abnormal—Fludarabine—lymphatic system cancer	0.00435	0.00435	CcSEcCtD
Miglustat—Asthenia—Teniposide—lymphatic system cancer	0.00431	0.00431	CcSEcCtD
Miglustat—Malaise—Bleomycin—lymphatic system cancer	0.00428	0.00428	CcSEcCtD
Miglustat—Mental disorder—Carmustine—lymphatic system cancer	0.00416	0.00416	CcSEcCtD
Miglustat—Malnutrition—Carmustine—lymphatic system cancer	0.00414	0.00414	CcSEcCtD
Miglustat—Diarrhoea—Teniposide—lymphatic system cancer	0.00411	0.00411	CcSEcCtD
Miglustat—Back pain—Carmustine—lymphatic system cancer	0.004	0.004	CcSEcCtD
Miglustat—Discomfort—Bleomycin—lymphatic system cancer	0.00399	0.00399	CcSEcCtD
Miglustat—Mental disorder—Vincristine—lymphatic system cancer	0.00398	0.00398	CcSEcCtD
Miglustat—Chills—Mitoxantrone—lymphatic system cancer	0.00397	0.00397	CcSEcCtD
Miglustat—Tremor—Carmustine—lymphatic system cancer	0.00388	0.00388	CcSEcCtD
Miglustat—Back pain—Vincristine—lymphatic system cancer	0.00382	0.00382	CcSEcCtD
Miglustat—Vomiting—Teniposide—lymphatic system cancer	0.00382	0.00382	CcSEcCtD
Miglustat—Thrombocytopenia—Bleomycin—lymphatic system cancer	0.00379	0.00379	CcSEcCtD
Miglustat—Asthenia—Fludarabine—lymphatic system cancer	0.00379	0.00379	CcSEcCtD
Miglustat—Headache—Teniposide—lymphatic system cancer	0.00376	0.00376	CcSEcCtD
Miglustat—Back pain—Mitoxantrone—lymphatic system cancer	0.00372	0.00372	CcSEcCtD
Miglustat—Anorexia—Bleomycin—lymphatic system cancer	0.00369	0.00369	CcSEcCtD
Miglustat—Diarrhoea—Fludarabine—lymphatic system cancer	0.00361	0.00361	CcSEcCtD
Miglustat—Convulsion—Carmustine—lymphatic system cancer	0.00359	0.00359	CcSEcCtD
Miglustat—Ill-defined disorder—Mitoxantrone—lymphatic system cancer	0.00357	0.00357	CcSEcCtD
Miglustat—Nausea—Teniposide—lymphatic system cancer	0.00357	0.00357	CcSEcCtD
Miglustat—Vertigo—Vincristine—lymphatic system cancer	0.00355	0.00355	CcSEcCtD
Miglustat—Paraesthesia—Bleomycin—lymphatic system cancer	0.00347	0.00347	CcSEcCtD
Miglustat—Malaise—Mitoxantrone—lymphatic system cancer	0.00347	0.00347	CcSEcCtD
Miglustat—Convulsion—Vincristine—lymphatic system cancer	0.00342	0.00342	CcSEcCtD
Miglustat—Decreased appetite—Bleomycin—lymphatic system cancer	0.00336	0.00336	CcSEcCtD
Miglustat—Visual disturbance—Methotrexate—lymphatic system cancer	0.00336	0.00336	CcSEcCtD
Miglustat—Vomiting—Fludarabine—lymphatic system cancer	0.00336	0.00336	CcSEcCtD
Miglustat—Convulsion—Mitoxantrone—lymphatic system cancer	0.00333	0.00333	CcSEcCtD
Miglustat—Pain—Bleomycin—lymphatic system cancer	0.00331	0.00331	CcSEcCtD
Miglustat—Thrombocytopenia—Carmustine—lymphatic system cancer	0.00331	0.00331	CcSEcCtD
Miglustat—Headache—Fludarabine—lymphatic system cancer	0.00331	0.00331	CcSEcCtD
Miglustat—Discomfort—Mitoxantrone—lymphatic system cancer	0.00324	0.00324	CcSEcCtD
Miglustat—Anorexia—Carmustine—lymphatic system cancer	0.00322	0.00322	CcSEcCtD
Miglustat—Feeling abnormal—Bleomycin—lymphatic system cancer	0.00319	0.00319	CcSEcCtD
Miglustat—Nervous system disorder—Vincristine—lymphatic system cancer	0.00316	0.00316	CcSEcCtD
Miglustat—Thrombocytopenia—Vincristine—lymphatic system cancer	0.00316	0.00316	CcSEcCtD
Miglustat—Nausea—Fludarabine—lymphatic system cancer	0.00313	0.00313	CcSEcCtD
Miglustat—Thrombocytopenia—Mitoxantrone—lymphatic system cancer	0.00307	0.00307	CcSEcCtD
Miglustat—Anorexia—Vincristine—lymphatic system cancer	0.00307	0.00307	CcSEcCtD
Miglustat—Insomnia—Carmustine—lymphatic system cancer	0.00305	0.00305	CcSEcCtD
Miglustat—Paraesthesia—Carmustine—lymphatic system cancer	0.00303	0.00303	CcSEcCtD
Miglustat—Anorexia—Mitoxantrone—lymphatic system cancer	0.00299	0.00299	CcSEcCtD
Miglustat—Ataxia—Methotrexate—lymphatic system cancer	0.00299	0.00299	CcSEcCtD
Miglustat—Decreased appetite—Carmustine—lymphatic system cancer	0.00294	0.00294	CcSEcCtD
Miglustat—Insomnia—Vincristine—lymphatic system cancer	0.00292	0.00292	CcSEcCtD
Miglustat—Gastrointestinal disorder—Carmustine—lymphatic system cancer	0.00292	0.00292	CcSEcCtD
Miglustat—Paraesthesia—Vincristine—lymphatic system cancer	0.0029	0.0029	CcSEcCtD
Miglustat—Constipation—Carmustine—lymphatic system cancer	0.00289	0.00289	CcSEcCtD
Miglustat—Pain—Carmustine—lymphatic system cancer	0.00289	0.00289	CcSEcCtD
Miglustat—Paraesthesia—Mitoxantrone—lymphatic system cancer	0.00282	0.00282	CcSEcCtD
Miglustat—Decreased appetite—Vincristine—lymphatic system cancer	0.0028	0.0028	CcSEcCtD
Miglustat—Gastrointestinal disorder—Vincristine—lymphatic system cancer	0.00278	0.00278	CcSEcCtD
Miglustat—Feeling abnormal—Carmustine—lymphatic system cancer	0.00278	0.00278	CcSEcCtD
Miglustat—Fatigue—Vincristine—lymphatic system cancer	0.00278	0.00278	CcSEcCtD
Miglustat—Asthenia—Bleomycin—lymphatic system cancer	0.00278	0.00278	CcSEcCtD
Miglustat—Dyspepsia—Mitoxantrone—lymphatic system cancer	0.00276	0.00276	CcSEcCtD
Miglustat—Gastrointestinal pain—Carmustine—lymphatic system cancer	0.00276	0.00276	CcSEcCtD
Miglustat—Pain—Vincristine—lymphatic system cancer	0.00276	0.00276	CcSEcCtD
Miglustat—Constipation—Vincristine—lymphatic system cancer	0.00276	0.00276	CcSEcCtD
Miglustat—Decreased appetite—Mitoxantrone—lymphatic system cancer	0.00273	0.00273	CcSEcCtD
Miglustat—Fatigue—Mitoxantrone—lymphatic system cancer	0.00271	0.00271	CcSEcCtD
Miglustat—Constipation—Mitoxantrone—lymphatic system cancer	0.00269	0.00269	CcSEcCtD
Miglustat—Pain—Mitoxantrone—lymphatic system cancer	0.00269	0.00269	CcSEcCtD
Miglustat—Abdominal pain—Carmustine—lymphatic system cancer	0.00267	0.00267	CcSEcCtD
Miglustat—Gastrointestinal pain—Vincristine—lymphatic system cancer	0.00264	0.00264	CcSEcCtD
Miglustat—Feeling abnormal—Mitoxantrone—lymphatic system cancer	0.00259	0.00259	CcSEcCtD
Miglustat—Gastrointestinal pain—Mitoxantrone—lymphatic system cancer	0.00257	0.00257	CcSEcCtD
Miglustat—Abdominal pain—Vincristine—lymphatic system cancer	0.00255	0.00255	CcSEcCtD
Miglustat—Abdominal pain—Mitoxantrone—lymphatic system cancer	0.00248	0.00248	CcSEcCtD
Miglustat—Vomiting—Bleomycin—lymphatic system cancer	0.00246	0.00246	CcSEcCtD
Miglustat—Depression—Methotrexate—lymphatic system cancer	0.00245	0.00245	CcSEcCtD
Miglustat—Asthenia—Carmustine—lymphatic system cancer	0.00242	0.00242	CcSEcCtD
Miglustat—Asthenia—Vincristine—lymphatic system cancer	0.00231	0.00231	CcSEcCtD
Miglustat—Diarrhoea—Carmustine—lymphatic system cancer	0.00231	0.00231	CcSEcCtD
Miglustat—Nausea—Bleomycin—lymphatic system cancer	0.0023	0.0023	CcSEcCtD
Miglustat—Asthenia—Mitoxantrone—lymphatic system cancer	0.00225	0.00225	CcSEcCtD
Miglustat—Dizziness—Carmustine—lymphatic system cancer	0.00223	0.00223	CcSEcCtD
Miglustat—Haemoglobin—Methotrexate—lymphatic system cancer	0.00221	0.00221	CcSEcCtD
Miglustat—Diarrhoea—Vincristine—lymphatic system cancer	0.00221	0.00221	CcSEcCtD
Miglustat—Haemorrhage—Methotrexate—lymphatic system cancer	0.0022	0.0022	CcSEcCtD
Miglustat—Diarrhoea—Mitoxantrone—lymphatic system cancer	0.00215	0.00215	CcSEcCtD
Miglustat—Vomiting—Carmustine—lymphatic system cancer	0.00215	0.00215	CcSEcCtD
Miglustat—Dizziness—Vincristine—lymphatic system cancer	0.00213	0.00213	CcSEcCtD
Miglustat—Visual impairment—Methotrexate—lymphatic system cancer	0.00212	0.00212	CcSEcCtD
Miglustat—Headache—Carmustine—lymphatic system cancer	0.00212	0.00212	CcSEcCtD
Miglustat—Eye disorder—Methotrexate—lymphatic system cancer	0.00206	0.00206	CcSEcCtD
Miglustat—Vomiting—Vincristine—lymphatic system cancer	0.00205	0.00205	CcSEcCtD
Miglustat—Headache—Vincristine—lymphatic system cancer	0.00202	0.00202	CcSEcCtD
Miglustat—Nausea—Carmustine—lymphatic system cancer	0.00201	0.00201	CcSEcCtD
Miglustat—Vomiting—Mitoxantrone—lymphatic system cancer	0.002	0.002	CcSEcCtD
Miglustat—Chills—Methotrexate—lymphatic system cancer	0.00198	0.00198	CcSEcCtD
Miglustat—Headache—Mitoxantrone—lymphatic system cancer	0.00197	0.00197	CcSEcCtD
Miglustat—Mental disorder—Methotrexate—lymphatic system cancer	0.00193	0.00193	CcSEcCtD
Miglustat—Malnutrition—Methotrexate—lymphatic system cancer	0.00192	0.00192	CcSEcCtD
Miglustat—Nausea—Vincristine—lymphatic system cancer	0.00192	0.00192	CcSEcCtD
Miglustat—Nausea—Mitoxantrone—lymphatic system cancer	0.00187	0.00187	CcSEcCtD
Miglustat—Back pain—Methotrexate—lymphatic system cancer	0.00185	0.00185	CcSEcCtD
Miglustat—Ill-defined disorder—Methotrexate—lymphatic system cancer	0.00178	0.00178	CcSEcCtD
Miglustat—Malaise—Methotrexate—lymphatic system cancer	0.00173	0.00173	CcSEcCtD
Miglustat—Vertigo—Methotrexate—lymphatic system cancer	0.00172	0.00172	CcSEcCtD
Miglustat—Convulsion—Methotrexate—lymphatic system cancer	0.00166	0.00166	CcSEcCtD
Miglustat—Discomfort—Methotrexate—lymphatic system cancer	0.00161	0.00161	CcSEcCtD
Miglustat—Nervous system disorder—Methotrexate—lymphatic system cancer	0.00153	0.00153	CcSEcCtD
Miglustat—Thrombocytopenia—Methotrexate—lymphatic system cancer	0.00153	0.00153	CcSEcCtD
Miglustat—Anorexia—Methotrexate—lymphatic system cancer	0.00149	0.00149	CcSEcCtD
Miglustat—Insomnia—Methotrexate—lymphatic system cancer	0.00141	0.00141	CcSEcCtD
Miglustat—Paraesthesia—Methotrexate—lymphatic system cancer	0.0014	0.0014	CcSEcCtD
Miglustat—Dyspepsia—Methotrexate—lymphatic system cancer	0.00138	0.00138	CcSEcCtD
Miglustat—Decreased appetite—Methotrexate—lymphatic system cancer	0.00136	0.00136	CcSEcCtD
Miglustat—Gastrointestinal disorder—Methotrexate—lymphatic system cancer	0.00135	0.00135	CcSEcCtD
Miglustat—Fatigue—Methotrexate—lymphatic system cancer	0.00135	0.00135	CcSEcCtD
Miglustat—Pain—Methotrexate—lymphatic system cancer	0.00134	0.00134	CcSEcCtD
Miglustat—Feeling abnormal—Methotrexate—lymphatic system cancer	0.00129	0.00129	CcSEcCtD
Miglustat—Gastrointestinal pain—Methotrexate—lymphatic system cancer	0.00128	0.00128	CcSEcCtD
Miglustat—Abdominal pain—Methotrexate—lymphatic system cancer	0.00124	0.00124	CcSEcCtD
Miglustat—Asthenia—Methotrexate—lymphatic system cancer	0.00112	0.00112	CcSEcCtD
Miglustat—Diarrhoea—Methotrexate—lymphatic system cancer	0.00107	0.00107	CcSEcCtD
Miglustat—Dizziness—Methotrexate—lymphatic system cancer	0.00103	0.00103	CcSEcCtD
Miglustat—Vomiting—Methotrexate—lymphatic system cancer	0.000995	0.000995	CcSEcCtD
Miglustat—Headache—Methotrexate—lymphatic system cancer	0.00098	0.00098	CcSEcCtD
Miglustat—Nausea—Methotrexate—lymphatic system cancer	0.000929	0.000929	CcSEcCtD
